Control of HIV co-receptor expression: implications for pathogenesis and treatment.
Rowland-Jones
S
S
Molecular Immunology Group, Institute of Molecular Medicine, Oxford, UK. sarah.rowland-jones@ndm.ox.ac.uk
Tan
R
R
D018106:CD28 Antigens / Q000378:metabolism; D017252:CD3 Complex / Q000378:metabolism; D015658:HIV Infections / Q000209:etiology* / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000639:trends; D008213:Lymphocyte Activation; D015728:Receptors, HIV / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology
D018106:CD28 Antigens; D017252:CD3 Complex; D015728:Receptors, HIV